Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Madeleine D. Burns, Brittany P. Boribong, Yannic C. Bartsch, Maggie Loiselle, Kerri J. St. Denis, Maegan L. Sheehan, Jessica W. Chen, Jameson P. Davis, Rosiane Lima, Andrea G. Edlow, Alessio Fasano, Alejandro B. Balazs, Galit Alter, Lael M. Yonker
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI AG 2022-03-01
Серии:Vaccines
Предметы:
SARS-CoV-2
COVID-19
pediatrics
adolescents
vaccines
boosters
Online-ссылка:https://www.mdpi.com/2076-393X/10/4/492
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы